Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Clinical trial NCT06111768 · COMPLETED

Trial details

NCT number: NCT06111768
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiorenal Syndrome

Start date: 2024-05-30
Primary completion: 2025-09-25
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.